(Q45364396)

13 December 2017

Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination (English)

1 reference

13 December 2017

1 reference

1 reference

neonatal hemochromatosis

1 reference

Chang-Lin Zhu

1

1 reference

13 December 2017

Ping Liu

2

1 reference

13 December 2017

Taoyang Chen

3

1 reference

13 December 2017

Zhengping Ni

4

1 reference

13 December 2017

Ling-Ling Lu

5

1 reference

13 December 2017

Fei Huang

6

1 reference

13 December 2017

Jianhua Lu

7

1 reference

13 December 2017

Zongtang Sun

8

1 reference

13 December 2017

Chunfeng Qu

9

1 reference

13 December 2017

language of work or name

English

0 references

publication date

2 August 2011

1 reference

13 December 2017

1 reference

13 December 2017

29

1 reference

13 December 2017

44

1 reference

13 December 2017

7835-7841

1 reference

Prevention and control of hepatitis B in China

13 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Trends in the incidence of cancer in Qidong, China, 1978-2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Determination of immune memory to hepatitis B vaccination through early booster response in college students.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Is a low dose of hepatitis B vaccine enough for a rapid vaccination scheme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Immune effectors required for hepatitis B virus clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Hepatitis B virus immunopathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

The influence of age on the development of the hepatitis B carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

Transfusion-transmitted hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.098

10.1016/J.VACCINE.2011.07.098

7 January 2021

Identifiers

DOI

1 reference

13 December 2017

1 reference